RT Journal Article
SR Electronic
T1 Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000587
DO 10.1136/jitc-2020-000587
VO 8
IS 1
A1 Overman, Michael
A1 Javle, Milind
A1 Davis, Richard E
A1 Vats, Pankaj
A1 Kumar-Sinha, Chandan
A1 Xiao, Lianchun
A1 Mettu, Niharika B
A1 Parra, Edwin R
A1 Benson, Al B
A1 Lopez, Charles D
A1 Munugalavadla, Veerendra
A1 Patel, Priti
A1 Tao, Lin
A1 Neelapu, Sattva
A1 Maitra, Anirban
YR 2020
UL http://jitc.bmj.com/content/8/1/e000587.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.